Pymaceuticals, Inc., a new pharmaceutical company that specializes in anti-cancer medications. Recently, it began screening for potential treatments for squamous cell carcinoma (SCC), a commonly occurring form of skin cancer.
In this study, 249 mice who were identified with SCC tumors received treatment with a range of drug regimens. Over the course of 45 days, tumor development was observed and measured. The purpose of this study was to compare the performance of Pymaceuticals’ drug of interest, Capomulin, against the other treatment regimens.
- There is a positive correlation between mouse weight and tumor volume
- Mouse which are treated on Capomulin drug saw a decrease in Tumor Volume.
- Ramicane is the best drug so far, which shows lowest Tumor volume and mean, median values
